Ingelise Saunders
Chief Executive Officer at iSD Immunotech ApS
Profile
Ingelise Saunders is the founder of TD Vaccines A, which was founded in 2009.
She is currently the Chairman & Chief Executive Officer of iSD Immunotech ApS since 2019, and also holds the position of Chief Executive Officer at Meta-IQ and Chairman at Minervax ApS.
Avilex Pharma ApS.
She has also served as a Director at Celltech Group Plc, Gyros AB, Topotarget A, ALK-Abello A, and LEO Pharma A, and as a Principal at Schering-Plough Corp.
Ms. Saunders's education includes an undergraduate and graduate degree from the University of Copenhagen.
Ingelise Saunders active positions
Companies | Position | Start |
---|---|---|
Minervax ApS
Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Chairman | - |
Meta-IQ | Chief Executive Officer | - |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Chief Executive Officer | - |
Former positions of Ingelise Saunders
Companies | Position | End |
---|---|---|
ONCOlog Medical QA AB
ONCOlog Medical QA AB Medical SpecialtiesHealth Technology ONCOlog Medical QA AB develops and markets system solutions for quality assurance of radiotherapy treatment clinics for cancer. Its products include IMRTLog, QAMLog, EcoLog, MachLog, TopLog, ChemoCare, EvidenceLog, and DocLog. The company was founded in 2002 and is headquartered in Uppsala, Sweden. | Director/Board Member | 2013-12-12 |
SLS Invest AB | Chief Executive Officer | 2013-08-31 |
EVOLVA HOLDING SA | Director/Board Member | 2011-05-17 |
UCB Nordic AS | Director/Board Member | 2004-12-31 |
Celltech Pharmaceuticals, Inc. | Chief Executive Officer | 2004-01-01 |
Training of Ingelise Saunders
University of Copenhagen | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
EVOLVA HOLDING SA | Consumer Non-Durables |
ALK-ABELLÓ A/S | Health Technology |
Private companies | 25 |
---|---|
ACE BioSciences ApS
ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology ACE BioSciences A/S engages in the research and experimental development on biotechnology. It offers medical research, production, and sale of medical products. The company was founded on September 15, 2000 and is headquartered in Hillerød, Denmark. | Health Technology |
Manipal Acunova Ltd.
Manipal Acunova Ltd. Miscellaneous Commercial ServicesCommercial Services Manipal Acunova Ltd. provides clinical research services. It offers clinical development services to the pharmaceutical, biotechnology, nutritional, device and medical diagnostics industries. The company was founded by Dodballapur Achuta Rao Prasanna in 2005 and is headquartered in Bangalore, India. | Commercial Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
Glaxo, Inc. | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Topotarget A/S
Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Nordic Vaccine A/S
Nordic Vaccine A/S Pharmaceuticals: MajorHealth Technology Nordic Vaccine A/S engages in the development and commercialization of vaccines for prophylactic and therapeutic use. It offers Posintro that combines delivery and immunological properties for the development of prophylactic and therapeutic vaccines. The firm also provides needle free delivery systems, including TransVac, a novel patch system for pain-free, non-invasive, and transdermal delivery of vaccines. The company was founded in 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
TD Vaccines A/S
TD Vaccines A/S Pharmaceuticals: MajorHealth Technology TD Vaccines A/S S is a holding company that focuses on the development of vaccines to protect against travellers' diarrhoea (TD). It is a biotechnology company that discovers and develops novel vaccines to fight serious bacterial infections. Its lead programme is ACE527, an oral ETEC vaccine to protect against ETEC (Enterotoxigenic E Coli). Its oral combination vaccine, ACE920, designs to protect against ETEC and Campylobacter infections. The company was founded in November 2009 and is headquartered in Skorping, Denmark. | Health Technology |
Action Pharma A/S
Action Pharma A/S BiotechnologyHealth Technology Action Pharma A/S is an R&D-focused biotech company located in the Nordic Medicon Valley area in Copenhagen, Denmark. Action Pharma was founded in 2000 and has a pipeline of 4 drug candidates in different stages of development, plus additional compounds in discovery and early preclinical development. Action Pharma pursues the discovery and development of new drugs and treatment concepts to treat cardiovascular diseases, inflammatory diseases and metabolic diseases, such as type-II diabetes and obesity. Its drug candidates are modified endogenous peptides with improved efficacy and small chemical entities targeted the melanocortin receptors. In disease models, its drug candidates have shown strong effects in treating and preventing inflammation and organ damage in conditions such as post-surgical organ dysfunction and acute myocardial infarction. A major focus for Action Pharma is treatment candidates for type-II diabetes, obesity and metabolic syndrome. Moreover, several drug candidates have shown effects in treating inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and dermatitis. | Health Technology |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
UCB Nordic AS | |
OpGen A/S
OpGen A/S Medical SpecialtiesHealth Technology Part of OpGen, Inc., OpGen A/S is a Danish company that develops and markets molecular-based in vitro diagnostic tests. The company is based in Vedbaek, Denmark. | Health Technology |
SLS Invest AB | Finance |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Health Technology |
AdvanDx, Inc.
AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA. | Health Technology |
ONCOlog Medical QA AB
ONCOlog Medical QA AB Medical SpecialtiesHealth Technology ONCOlog Medical QA AB develops and markets system solutions for quality assurance of radiotherapy treatment clinics for cancer. Its products include IMRTLog, QAMLog, EcoLog, MachLog, TopLog, ChemoCare, EvidenceLog, and DocLog. The company was founded in 2002 and is headquartered in Uppsala, Sweden. | Health Technology |
Medical Vision AB
Medical Vision AB Medical SpecialtiesHealth Technology Medical Vision AB provides medical devices used during endoscopic surgeries. It develops, manufactures and markets medical devices within the field of Arthroscopic surgery. The firm's core product is called Double Pump, and is used to flush fluids through the joint with a controlled pressure and flow to increase visualization during the procedure. The company was founded by Anders Gunnar Möllstam in 2003 and is headquartered in Nacka, Sweden. | Health Technology |
Avilex Pharma ApS
Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Health Technology |
Minervax ApS
Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
Ferrosan ApS
Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. | Health Technology |
Celltech Pharmaceuticals, Inc. | |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Acesion Pharma ApS
Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
Meta-IQ | |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Health Technology |
- Stock Market
- Insiders
- Ingelise Saunders